EpiCentre Holdings Ltd
SGX:5MQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
EpiCentre Holdings Ltd
SGX:5MQ
|
SG |
|
I
|
Ikab Securities and Investment Ltd
BSE:514238
|
IN |
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
JP |
|
N
|
Novo Resources Corp
SWB:1NO
|
CA |
|
P
|
PXP Energy Corp
XPHS:PXP
|
PH |
Cash Flow Statement
Cash Flow Statement
EpiCentre Holdings Ltd
| Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
4
|
2
|
2
|
3
|
4
|
8
|
6
|
1
|
1
|
(1)
|
(1)
|
(4)
|
(3)
|
(2)
|
(3)
|
(4)
|
(6)
|
(5)
|
1
|
(2)
|
(3)
|
(6)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
2
|
0
|
0
|
1
|
2
|
2
|
1
|
1
|
2
|
0
|
4
|
|
| Cash Taxes Paid |
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Change in Working Capital |
(3)
|
(3)
|
1
|
(0)
|
(4)
|
(3)
|
1
|
(1)
|
(2)
|
3
|
(1)
|
(4)
|
(7)
|
0
|
3
|
(2)
|
3
|
(3)
|
(12)
|
(5)
|
3
|
4
|
|
| Cash from Operating Activities |
1
N/A
|
(1)
N/A
|
4
N/A
|
4
-11%
|
0
-87%
|
6
+1 178%
|
8
+39%
|
1
-85%
|
1
-57%
|
4
+587%
|
(2)
N/A
|
(5)
-182%
|
(8)
-56%
|
0
N/A
|
2
+554%
|
(3)
N/A
|
0
N/A
|
(6)
N/A
|
(9)
-46%
|
(4)
+61%
|
0
N/A
|
2
+1 689%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+89%
|
(0)
-550%
|
(1)
-285%
|
(2)
-90%
|
(1)
+36%
|
(1)
-20%
|
(2)
-36%
|
(2)
-13%
|
(2)
+18%
|
(1)
+21%
|
(1)
+7%
|
(1)
+58%
|
(1)
-68%
|
(1)
-12%
|
(0)
+57%
|
(0)
+85%
|
(0)
-18%
|
0
N/A
|
(1)
N/A
|
(2)
-130%
|
(1)
+56%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
4
|
(1)
|
3
|
8
|
3
|
(1)
|
(2)
|
(2)
|
(2)
|
4
|
4
|
(0)
|
1
|
(2)
|
|
| Cash Paid for Dividends |
0
|
(2)
|
(2)
|
(0)
|
0
|
(2)
|
(3)
|
(5)
|
(4)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(2)
|
(0)
|
(0)
|
0
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
1
|
2
|
0
|
0
|
|
| Cash from Financing Activities |
5
N/A
|
3
-28%
|
(3)
N/A
|
(1)
+78%
|
1
N/A
|
0
-28%
|
(1)
N/A
|
(3)
-191%
|
(0)
+93%
|
(1)
-429%
|
2
N/A
|
8
+296%
|
3
-62%
|
(1)
N/A
|
(2)
-61%
|
(2)
-12%
|
(3)
-36%
|
8
N/A
|
10
+26%
|
2
-84%
|
1
-33%
|
(2)
N/A
|
|
| Change in Cash | |||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Net Change in Cash |
6
N/A
|
3
-53%
|
1
-54%
|
2
+62%
|
(1)
N/A
|
5
N/A
|
6
+9%
|
(4)
N/A
|
(2)
+51%
|
1
N/A
|
(1)
N/A
|
1
N/A
|
(6)
N/A
|
(2)
+66%
|
(1)
+53%
|
(6)
-558%
|
(3)
+45%
|
2
N/A
|
1
-33%
|
(3)
N/A
|
(0)
+84%
|
(1)
-177%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
1
N/A
|
(1)
N/A
|
4
N/A
|
3
-32%
|
(1)
N/A
|
5
N/A
|
7
+43%
|
(1)
N/A
|
(2)
-86%
|
2
N/A
|
(3)
N/A
|
(6)
-100%
|
(8)
-33%
|
(1)
+93%
|
1
N/A
|
(3)
N/A
|
0
N/A
|
(6)
N/A
|
(9)
-47%
|
(5)
+50%
|
(2)
+66%
|
1
N/A
|
|